From: Impact of anemia on in-stent restenosis after percutaneous coronary intervention
Variable | OR | 95% CI | P value |
---|---|---|---|
Gender | 0.708 | 0.319–1.571 | 0.396 |
Age | 1.003 | 0.967–1.042 | 0.858 |
Current smoker | 1.020 | 0.473–2.199 | 0.961 |
BMI | 0.908 | 0.788–1.046 | 0.179 |
Hypertension | 1.186 | 0.544–2.587 | 0.668 |
Diabetes mellitus | 2.588 | 1.176–5.696 | 0.018 |
LDL-c | 1.651 | 1.187–2.296 | 0.003 |
TG | 0.813 | 0.489–1.353 | 0.426 |
LVEF | 0.958 | 0.916–1.001 | 0.057 |
Anemia | 4.283 | 1.949–9.410 | < 0.001 |
CKD | 3.058 | 1.289–7.252 | 0.011 |
ACS | 0.948 | 0.442–2.033 | 0.890 |
Multiple stenting | 2.592 | 1.205–5.573 | 0.015 |
Stent length (mm) | 0.974 | 0.908–1.044 | 0.456 |
Stent diameter (mm) | 3.413 | 1.361–8.547 | 0.009 |
Multivessel coronary disease | 1.176 | 0.464–2.980 | 0.732 |
LMCA | 3.846 | 0.801–18.460 | 0.092 |
LAD | 1.933 | 0.794–4.707 | 0.146 |
LCX | 2.191 | 0.992–4.840 | 0.052 |
RCA | 0.508 | 0.212–1.218 | 0.129 |
Bifurcation lesion | 2.669 | 1.236–5.763 | 0.012 |
Calcification | 3.529 | 1.131–11.014 | 0.030 |
Statins | 0.727 | 0.164–3.223 | 0.674 |
Aspirin | NA | NA | NA |
Clopidogrel | 0.853 | 0.397–1.828 | 0.683 |
Ticagrelor | 0.693 | 0.314–1.530 | 0.364 |